methods 20 male healthy subjects received a single dose of 150 mg roxithromycin enterosoluble capsules.

1、

clinical pharmacokinetics and relative bioavailability of roxithromycin capsule

罗红霉素胶囊剂的临床药物动力学及相对生物利用度

互联网摘选

2、

study on pharmacokinetic and bioavailability of roxithromycin capsule and granule

罗红霉素胶囊剂和颗粒剂药代动力学和相对生物利用度研究

互联网摘选

3、

the relative bioavailability was 96.26% of roxithromycin capsule.

结论：罗红霉素胶囊与罗力得片为生物等效制剂，罗红霉素胶囊的相对生物利用度为96.26%。

互联网摘选

4、

in order to obtain the optimum formula and preparing techniques of roxithromycin capsules, the effects of different excipients and techniques were studied with orthogonal test.

为筛选罗红霉素胶囊的最佳处方和制备工艺，用正交试验法，考察不同辅料和制备工艺对罗红霉素胶囊的质量影响。

互联网摘选

5、

roxithromycin capsules microbial limit test method

罗红霉素胶囊微生物限度检查法的验证

互联网摘选

6、

conclusion: honghua injection and shensong yangxin capsule has the effect of lowering lipids, anticoagulation, expanding coronary artery and improving heart function.

结论：红花注射液合参松养心胶囊具有降脂、抗凝、扩张冠脉，改善心功能的临床效果。

provided by jukuu

7、

study effect of shen qi tang shen an on oxidative stress reaction of rats with diabetic nephropathy

参松养心胶囊联合黄芪颗粒治疗心肌炎伴室上性早搏的临床观察参芪糖肾安颗粒对糖尿病肾病大鼠氧化应激反应的影响

互联网摘选

8、

clinical study on treatment of ventricular premature beats with shen song yang xin capsule

参松养心胶囊治疗室性早搏的疗效观察

互联网摘选

9、

conclusion the efficacy of hemostasis is satisfactory by gastroscopic spraying yunnan powder combined with lansoprazole capsules mixed with normal saline in the peptic ulcer bleeding foci.

结论在胃镜确诊下，应用云南白药散剂联合兰索拉唑胶囊混合溶解液喷洒溃疡出血灶止血临床效果满意。

互联网摘选

10、

methods in the observation group, 42 cases received the treatment of gastroscopic spraying yunnan powder combined with lansoprazole capsules mixed with normal saline.

方法观察组42例用云南白药散剂与兰索拉唑胶囊溶解液治疗；

互联网摘选

11、

effect of yunnan baiyao powder capsule on capillary leak syndrome of severe preeclampsia

云南白药胶囊治疗重度子痫前期毛细血管渗漏综合征

互联网摘选

12、

determination of fenofibrate soft capsules by hplc method

HPLC法测定非诺贝特软胶囊的有关物质及含量

互联网摘选

13、

bioavailability of lipantil capsule ( micronized) in human body

非诺贝特胶囊（微粒化）人体生物利用度研究

互联网摘选

14、

results 1 in the same experimental conditions, the minimal efficacious dose of the micronised fenofibrate is 30 mg · kg-1, but that of the standard fenofibrate is 80 mg · kg-1;

结果①相同实验条件下，微粉化非诺贝特胶囊降低高血脂大鼠血清TC和TG的最低有效剂量为每天30mg·kg-1，而标准化非诺贝特胶囊为每天80mg·kg-1；

互联网摘选

15、

determination of content and uniformity of chlorphenamine maleate in ganteling capsules by hplc;

建立了咳特灵胶囊中马来酸氯苯那敏含量的高效毛细管电泳-电导测定法。

互联网摘选

16、

the clinical effect of the treatment of chronic glomerulonephritis with tongxin luo capsule was observed and was compared with the effect of the treatment with angiotensin converting enzyme inhibitor ( acei).

本文观察了通心络胶囊治疗慢性肾小球肾炎的临床疗效，并与血管紧张素转换酶抑制剂进行了比较研究。

互联网摘选

17、

the possible mechanisms of efficiency of the treatment of chronic glomerulonephritis with tongxin luo capsule are studied theoretically in the final part of the thesis.

文章最后对通心络胶囊治疗慢性肾炎的可能疗效机制进行了探讨。

互联网摘选

18、

objective: to investigate the prevention and treatment effect of tongxinluo capsule on myocardial microvascular inflammatory damage and vascular spasm in goto-kakizaki diabetes prone rats.

目的：观察通心络胶囊对自发性糖尿病模型大鼠心肌微血管炎症损伤及血管痉挛的防治作用。

互联网摘选

19、

objective to explore the effects of tongxinluo capsules on local cerebral blood flow and clinical nerve function defect in patients with cerebral infarction.

目的探讨通心络胶囊对脑梗死局部脑血流变化与临床神经功能缺损改善的关系。

互联网摘选

20、

objective: to probe probe the clinical effect and mechanism of tongxinluo capsule in preventing and treating coronary restenosis after ptca.

目的：旨在探讨通心络胶囊防治经皮腔内冠状动脉成形术后再狭窄的临床作用及机制。

互联网摘选